Buy Trevi Therapeutics Inc Stock | TRVI Stock Price & Latest News | Public.com
TRVI

Trevi Therapeutics Inc

$0.00 (0.00%)Today
    Small Market Cap
    View Trevi Therapeutics Inc (TRVI) stock trends here

    About TRVI

    Trevi Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of treatment for neurologically mediated conditions. It focuses on the formulation of nalbuphine ER, which use to treat chronic pruritus, chron...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.16
    -0.33
    -0.49
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.49

    Actual EPS
    Q1 2021

    Stats

    Market Cap$51,83M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$8.50
    1 Year Low$1.33
    Open$2.94
    High$3.02
    Low$2.89

    Buy any stock with any amount of money.

    Download the App
    Download the app